Imricor Medical Systems, Inc.
ASX: IMR
Strong expansion plans overshadowed by weakening momentum and rising near-term downside risk
Stock Performance Profile:
(Source: TradingView) 3-Month Performance Profile of IMR on a DTF compared to S&P/ASX 200 (XJO).
Imricor Medical Systems continued to advance the commercial rollout of its MRI-guided cardiac ablation platform, re
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
